SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results
29 mars 2022 16h30 HE
|
SAB Biotherapeutics, Inc.
SAB executing on its strategy to build a proprietary immune and autoimmune disorders pipeline, including respiratory diseases that affect immunocompromised patients Plans to announce full data...